AS INBANK financials
AS INBANK
2138005M92IEIQVEL297 | Line item | 2021 | 2020 |
|---|---|---|
| Income statement | ||
| Other income | €19.3M | €768.0K |
| Administrative expenses | €6.6M | €4.2M |
| Operating expenses | €24.4M | €17.3M |
| Employee benefits expense | €11.6M | €9.2M |
| Depreciation & amortisation | €3.4M | €2.3M |
| Profit before tax | €12.3M | €6.8M |
| Income tax expense | €1.3M | €867.0K |
| Profit for the year | €11.0M | €5.9M |
| Total comprehensive income | €10.9M | €5.7M |
| Cash flow statement | ||
| Net cash from operating activities | €50.2M | -€43.7M |
| Net cash from investing activities | -€19.3M | -€18.8M |
| Net cash from financing activities | €12.1M | €7.6M |
| Lease liability payments | €10.0M | €592.0K |
| Balance sheet | ||
| Total assets | €787.0M | €490.0M |
| Property, plant & equipment | €19.1M | €833.0K |
| Right-of-use assets | €25.2M | €1.2M |
| Intangible assets & goodwill | €22.4M | €16.1M |
| Cash & equivalents | €87.4M | €44.5M |
| Total equity | €79.0M | €61.2M |
| Deferred tax liabilities | €125.0K | €0 |
| Derived metrics | ||
| Return on equity | 13.9% | 9.6% |
| Cash conversion ratio | 4.57× | -7.41× |
| Other reported items | ||
| Adjustments For Decrease Increase In Loans and Advances To Customers | -€210.2M | -€77.4M |
| Adjustments For Decrease Increase In Other Assets | €1.1M | -€552.0K |
| Adjustments For Increase Decrease In Deposits From Customers | €224.5M | €11.9M |
| Adjustments For Increase Decrease In Other Liabilities | €10.2M | €287.0K |
| Balances With Banks | €17.9M | €19.8M |
| Cash and Bank Balances At Central Banks | €77.5M | €27.4M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €29.8M | €20.2M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €3.4M | -€926.0K |
| Current Tax Liabilities | €284.0K | €864.0K |
| Debt Securities | €0 | €4.0M |
| Deferred Tax Assets | €2.4M | €2.2M |
| Deposits From Customers | €617.9M | €391.3M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€23.0K | -€301.0K |
| Equity and Liabilities | €787.0M | €490.0M |
| Fee and Commission Expense | €3.1M | €2.5M |
| Fee and Commission Income | €2.2M | €1.4M |
| Fee and Commission Income Expense | -€917.0K | -€1.1M |
| Financial Assets At Amortised Cost | €7.7M | €13.6M |
| Gains Losses On Exchange Differences On Translation Net of Tax | -€59.0K | -€219.0K |
| Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 | €6.7M | €11.5M |
| Income Taxes Paid Refund Classified As Operating Activities | €1.9M | €693.0K |
| Increase Decrease In Cash and Cash Equivalents | €42.9M | -€54.7M |
| Increase Decrease Through Sharebased Payment Transactions | €281.0K | €207.0K |
| Increase Decrease Through Transfer To Statutory Reserve | €0 | €0 |
| Inflows of Cash From Investing Activities | €12.2M | €0 |
| Interest Expense | €9.6M | €7.9M |
| Interest Paid Classified As Operating Activities | €7.5M | €5.9M |
| Interest Received Classified As Operating Activities | €47.5M | €43.3M |
| Interest Revenue Calculated Using Effective Interest Method | €48.0M | €43.0M |
| Interest Revenue Expense | €38.4M | €35.2M |
| Investments In Associates | €774.0K | €4.0M |
| Issue of Equity | €6.6M | €8.0M |
| Issued Capital | €997.0K | €961.0K |
| Liabilities | €707.9M | €428.8M |
| Loans and Advances To Customers | €604.8M | €402.2M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €4.2M | €0 |
| Other Assets | €2.8M | €1.3M |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €6.3M | €13.6M |
| Other Comprehensive Income | -€59.0K | -€219.0K |
| Other Expense By Nature | €13.8M | €0 |
| Other Financial Assets | €2.2M | €1.4M |
| Other Financial Liabilities | €49.2M | €12.2M |
| Other Liabilities | €3.3M | €2.8M |
| Other Operating Income Expense | €43.0M | €34.8M |
| Other Reserves | €1.6M | €1.4M |
| Payments To and On Behalf of Employees | €11.5M | €9.2M |
| Payments To Suppliers For Goods and Services | €7.2M | €6.9M |
| Proceeds From Issue of Subordinated Liabilities | €19.5M | €0 |
| Proceeds From Issuing Shares | €6.6M | €8.2M |
| Receipts From Royalties Fees Commissions and Other Revenue | €2.2M | €1.4M |
| Repayments of Bonds Notes and Debentures | €4.0M | €0 |
| Retained Earnings | €45.9M | €34.9M |
| Sales and Marketing Expense | €2.8M | €1.6M |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €335.0K | €789.0K |
| Share Premium | €30.4M | €23.9M |
| Statutory Reserve | €96.0K | €90.0K |
| Subordinated Liabilities | €37.2M | €17.6M |
Every line item above is a fact tagged in AS INBANK's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.